Literature DB >> 30199453

Preliminary Investigation Into the Effect of ACTN3 and ACE Polymorphisms on Muscle and Performance Characteristics.

John P Wagle1, Kevin M Carroll1, Aaron J Cunanan1, Alexander Wetmore1, Christopher B Taber2, Brad H DeWeese1, Kimitake Sato1, Charles A Stuart3, Michael H Stone1.   

Abstract

ABSTRACT: Wagle, JP, Carroll, KM, Cunanan, AJ, Wetmore, A, Taber, CB, DeWeese, BH, Sato, K, Stuart, CA, and Stone, MH. Preliminary investigation into the effect of ACTN3 and ACE polymorphisms on muscle and performance characteristics. J Strength Cond Res 35(3): 688-694, 2021-The purpose of this investigation was to explore the phenotypic and performance outcomes associated with ACTN3 and ACE polymorphisms. Ten trained men (age = 25.8 ± 3.0 years, height = 183.3 ± 4.1 cm, body mass = 92.3 ± 9.3 kg, and back squat to body mass ratio = 1.8 ± 0.3) participated. Blood samples were analyzed to determine ACTN3 and ACE polymorphisms. Standing ultrasonography images of the vastus lateralis (VL) were collected to determine whole muscle cross-sectional area (CSA-M), and a percutaneous muscle biopsy of the VL was collected to determine type I-specific CSA (CSA-T1), type II-specific CSA (CSA-T2), and type II to type I CSA ratio (CSA-R). Isometric squats were performed on force platforms with data used to determine peak force (IPF), allometrically scaled peak force (IPFa), and rate of force development (RFD) at various timepoints. One repetition maximum back squats were performed, whereby allometrically scaled dynamic strength (DSa) was determined. Cohen's d effect sizes revealed ACTN3 RR and ACE DD tended to result in greater CSA-M but differ in how they contribute to performance. ACTN3 RR's influence seems to be in the type II fibers, altering maximal strength, and ACE DD may influence RFD capabilities through a favorable CSA-R. Although the findings of the current investigation are limited by the sample size, the findings demonstrate the potential influence of ACTN3 and ACE polymorphisms on isometric and dynamic strength testing. This study may serve as a framework to generate hypotheses regarding the effect of genetics on performance.
Copyright © 2018 National Strength and Conditioning Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 30199453     DOI: 10.1519/JSC.0000000000002809

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  5 in total

1.  Acute Effects of Cluster and Rest Redistribution Set Structures on Mechanical, Metabolic, and Perceptual Fatigue During and After Resistance Training: A Systematic Review and Meta-analysis.

Authors:  Ivan Jukic; Amador García Ramos; Eric R Helms; Michael R McGuigan; James J Tufano
Journal:  Sports Med       Date:  2020-12       Impact factor: 11.136

2.  Responses to Maximal Strength Training in Different Age and Gender Groups.

Authors:  Hans Torvild Kittilsen; Sannija Goleva-Fjellet; Baard Ingegerdsson Freberg; Iver Nicolaisen; Eva Maria Støa; Solfrid Bratland-Sanda; Jan Helgerud; Eivind Wang; Mona Sæbø; Øyvind Støren
Journal:  Front Physiol       Date:  2021-02-17       Impact factor: 4.566

3.  Muscle Work and Its Relationship with ACE and ACTN3 Polymorphisms Are Associated with the Improvement of Explosive Strength.

Authors:  Alberto Melián Ortiz; Sofía Laguarta-Val; David Varillas-Delgado
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

Review 4.  Genetics and sports performance: the present and future in the identification of talent for sports based on DNA testing.

Authors:  David Varillas-Delgado; Juan Del Coso; Jorge Gutiérrez-Hellín; Millán Aguilar-Navarro; Alejandro Muñoz; Antonio Maestro; Esther Morencos
Journal:  Eur J Appl Physiol       Date:  2022-04-16       Impact factor: 3.346

5.  Genetic profiles to identify talents in elite endurance athletes and professional football players.

Authors:  David Varillas-Delgado; Esther Morencos; Jorge Gutiérrez-Hellín; Millán Aguilar-Navarro; Alejandro Muñoz; Nuria Mendoza Láiz; Teresa Perucho; Antonio Maestro; Juan José Tellería-Orriols
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.